PTN Palatin Technologies Inc.

$PTN $RYTM $DRUG HC Wainwright launched research coverage today on PTN with $12 that price ~100% upside. I think that is conservative and room to raise once they get their next gen MC4R lipidated peptide to provide potentially less than weekly doing vs vs current SOC that doses injections daily and just caught a bug for $10BILLION.PTN is the only other Nasdaq listed MC4R platform and i think smart money investors could act similarly to how DRUG rallied went up 50X+ in two weeks that followed the larger comp $2.4bn Longboard acquisition in sympathy… and here we are with potential $10B comp RYTM take out with PTN… sitting at tiny mkt cap - would be a cheap way for big pharma to hedge RYTM competition …and at a minimum assuages my concerns about the funding overhang and tax loss selling in near term. Dare i say… I think the bottom is in!! GLTA

$PTN Strong Q3 beat for $RYTM ( the only commercially avail MC4R drug) and valued at ~$7BN mkt cap reinforces my conviction in upside for MC4R assets esp future prospects for next gen assets and the only other publicly listed co $PTN…icurrently trading at under $10M mkt cap…shocking! Interestingly, RYTM amended its biva (next gen oral) license with LG Chem agreeing to pay $350M in exchange for reducing the royalty to 1%, from low MSDs. That further reinforces IMO they have confidence in upside for next gen assets which bodes really well for PTN which preclinically may be even more competitive but will have to see in clinic. Yes there has been delays but new preclin data promising for their lipid (next gen asset) safety and potentially offer less than weekly dosing so fundamentals IMO totally disconnected from price. Get thru tax loss selling and remove funding overhang to recover. Im adding back once again this val’n makes zero sense with risk reward attractive. GLTA

$PTN So far no dilution. I tĥink they will do everuthing in their power to raise money without a dilution. A dilution would kill the stock and the company.

$PTN 🤝 Cavitation Technologies, Inc.'s board recommends shareholders tender their shares in BrightFlixx Finance (Luxembourg) S.A.'s cash tender offer for all outstanding shares of the company. Market-relevant event

$PTN 🤝 BrightFlixx Finance (Luxembourg) S.A. commenced concurrent cash tender offers to acquire all outstanding shares of Cavitation Technologies, Inc. and Alchemy Beverages Inc. Prioritized by relevance

$PTN $RYTM $DRUG what caused $PTN to drop so much recently? Gets back to $19 and that's almost a 4 bagger. Gonna do a little for DD and buy next week if all looks promising. Anything anyone can add would be appreciated.

$PTN what if management actually bought some stock here?? ZERO insider purchases. Why would I put my money here they won’t?